Dr Reddy's, BioMarin settle patent litigation on Kuvan tablets
The California-based BioMarin Pharmaceutical has entered into a settlement agreement with Dr Reddy's Laboratories to resolve patent litigation in the US regarding Kuvan, the former's 100mg oral tablets.
Sep 21, 2015, 12:41 PM IST